izpis_h1_title_alt

Rehoming and other refinements and replacement in procedures using golden hamsters in SARS-CoV-2 vaccine research
ID Štrbenc, Malan (Author), ID Kuhar, Urška (Author), ID Lainšček, Duško (Author), ID Orehek, Sara (Author), ID Slavec, Brigita (Author), ID Krapež, Uroš (Author), ID Malovrh, Tadej (Author), ID Majdič, Gregor (Author)

.pdfPDF - Presentation file, Download (933,02 KB)
MD5: F3BCC75B5BDE711662C53F04F9171E69
URLURL - Source URL, Visit https://www.mdpi.com/2076-2615/13/16/2616 This link opens in a new window

Abstract
Effective vaccines are needed to fight the COVID-19 pandemic. Forty golden hamsters were inoculated with two promising vaccine candidates and eighteen animals were used in pilot trials with viral challenge. ELISA assays were performed to determine endpoint serum titres for specific antibodies and virus neutralisation tests were used to evaluate the efficacy of antibodies. All tests with serum from vaccinated hamsters were negative even after booster vaccinations and changes in vaccination protocol. We concluded that antibodies did not have sufficient neutralising properties. Refinements were observed at all steps, and the in vitro method (virus neutralisation test) presented a replacement measure and ultimately lead to a reduction in the total number of animals used in the project. The institutional animal welfare officer and institutional designated veterinarian approved the reuse or rehoming of the surplus animals. Simple socialization procedures were performed and ultimately 19 animals were rehomed, and feedback was collected. Recently, FELASA published recommendations for rehoming of animals used for scientific and educational purposes, with species-specific guidelines, including mice, rats, and rabbits. Based on our positive experience and feedback from adopters, we concluded that the rehoming of rodents, including hamsters, is not only possible, but highly recommended.

Language:English
Keywords:vaccines, mesocricetus, Models, animal, SARS-CoV-2
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:16 str.
Numbering:Vol. 13, iss. 16, [art. no.] 2616
PID:20.500.12556/RUL-148332 This link opens in a new window
UDC:636.09:578
ISSN on article:2076-2615
DOI:10.3390/ani13162616 This link opens in a new window
COBISS.SI-ID:161400579 This link opens in a new window
Publication date in RUL:16.08.2023
Views:735
Downloads:65
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Animals
Shortened title:Animals
Publisher:MDPI AG
ISSN:2076-2615
COBISS.SI-ID:519120409 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:16.08.2023

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Funder:ARRS - Slovenian Research Agency
Project number:P4-0092
Name:Zdravje živali, okolje in varna hrana

Funder:ARRS - Slovenian Research Agency
Project number:P4-0176
Name:Sintezna biologija in imunologija

Funder:ARRS - Slovenian Research Agency
Project number:V4-2038
Name:DNK cepiva in peptidnih inhibitorji proti SARS-CoV-2

Funder:ARRS - Slovenian Research Agency
Project number:J4-4563
Name:Uporaba izboljšanega sistema CRISPR/Cas za ne-virusno produkcijo celic CAR-T

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back